12:00 AM
Dec 10, 2012
 |  BC Week In Review  |  Company News  |  Deals

NanoPass Technologies, J&J deal

Johnson & Johnson's Janssen Pharmaceuticals Inc. received exclusive rights to use NanoPass' MicronJet microneedle intradermal delivery device for use in Janssen's seasonal...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >